Sara M. Hall
Geschäftsführer bei Hubble Therapeutics, Inc.
Profil
Sara M.
Hall was the founder of Tacere Therapeutics, Inc. which was founded in 2006, where she held the title of Chief Executive Officer.
Currently, she is the Chief Operating Officer at Hubble Therapeutics, Inc. Ms. Hall's former positions include Chief Executive & Operating Officer at Benitec Biopharma Ltd., and Principal at both Boehringer Ingelheim Corp.
and B-Bridge International, Inc.
Aktive Positionen von Sara M. Hall
| Unternehmen | Position | Beginn |
|---|---|---|
Hubble Therapeutics, Inc.
 Hubble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Hubble Therapeutics, Inc. develops therapies for genetic eye disorders. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Sara M. Hall
| Unternehmen | Position | Ende |
|---|---|---|
B-Bridge International, Inc.
 B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Präsident | - |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Tacere Therapeutics, Inc.
 Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
B-Bridge International, Inc.
B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Health Technology |
Hubble Therapeutics, Inc.
Hubble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Hubble Therapeutics, Inc. develops therapies for genetic eye disorders. | Commercial Services |
